Undervalued Small-Cap Healthcare Stocks on TSX March 2025

March 19, 2025

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

TSX Venture Exchange

The TSX Venture Exchange is a stock exchange headquartered in Calgary, Alberta, Canada. It is an exchange for the securities of early-stage businesses.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
ADK Diagnos - - 0.00 - 0 0.00 0.0
AJA AJA Health and Wellness - - 0.00 - 0 0.00 0.0
AQS Aequus Pharmaceuticals - - 0.00 - 0 0.00 0.0
ARC ARCpoint - - 0.00 - 0 0.00 0.0
ARCH Arch Biopartners - - 0.00 - 0 0.00 0.0
ASG Aurora Spine - - 0.00 - 0 0.00 0.0
AVCR Avricore Health - - 0.00 - 0 0.00 0.0
CANB CanadaBis Cap - - 0.00 - 0 0.00 0.0
CHS Comprehensive Healthcare - - 0.00 - 0 0.00 1.6
CNVI Conavi Medical - - 0.00 - 0 0.00 0.0
All data provided as at market close March 18, 2025.

Company Details

Diagnos

ADK:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.

Access the stockcalc valuation


AJA Health and Wellness

AJA:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

AJA Health and Wellness Inc is engaged in operating a telemedicine platform and full-service travel clinics, offering health insurance options, employee benefit packages, and natural skincare and pain relief products.

Access the stockcalc valuation


Aequus Pharmaceuticals

AQS:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Access the stockcalc valuation


ARCpoint

ARC:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

ARCpoint Inc is a US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing, and physician services for ARCpoint franchise labs and other clients.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Arch Biopartners

ARCH:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.

Access the stockcalc valuation


Aurora Spine

ASG:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.

Access the stockcalc valuation


Avricore Health

AVCR:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.

Access the stockcalc valuation


CanadaBis Cap

CANB:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards.

Access the stockcalc valuation


Comprehensive Healthcare

CHS:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

1.6

Comprehensive Healthcare Systems Inc is the provider of healthcare administrative software, licensing, and maintenance services to various interests in the healthcare industry, including insurance companies, hospitals, doctors, and labor unions.

Access the stockcalc valuation


Conavi Medical

CNVI:TSX-V

Close Price

-

Our Valuation

-

% Difference

0.00

Market Cap ($M)

0

P/E Ratio

0.0

Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Diagnos and AJA Health and Wellness are the most undervalued Small-Cap Healthcare stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tsx-march-2025
Diagnos $ADK and AJA Health and Wellness $AJA are the most undervalued Healthcare stocks on the #TSX. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tsx-march-2025
Diagnos and AJA Health and Wellness are the most undervalued Small-Cap Healthcare stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tsx-march-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.